Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03465748 · ClinicalTrials.gov registry record · NA
Effectiveness of Orthokeratology in Myopia Control
A NA study, sponsored by Illinois College of Optometry.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03465748 is a NA study that has completed, run by Illinois College of Optometry. The registered enrollment target is 45 participants.
The verdict
NCT03465748, a NA study, has completed, sponsored by Illinois College of Optometry.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The high prevalence of myopia - especially in Asian countries - is well documented, as are the sight-threatening complications of high or degenerative myopia. Retinal detachment, glaucoma, vitreal degeneration and focal retinal changes may occur secondary to the progressive axial elongation of the eye with age. Specialty rigid lenses have long been shown to lessen this progression in the pediatric population; orthokeratology (ortho-k) lenses are worn at night and change the corneal topography to correct low to moderate amounts of myopia. Most of the studies on orthokeratology were conducted on Asian children. To the best of the investigators knowledge, no study has been done on African American (AA) children. The investigators' project seeks to investigate the efficacy of ortho-k in slowing axial elongation and myopic progression in AA children compared to that in other races.
Interventions
- DEVICE OrthoK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03465748
The ClinicalTrials.gov registry entry for NCT03465748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Illinois College of Optometry, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OrthoK is the first listed.
NCT03465748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03465748 about?
NCT03465748 is a clinical study titled "Effectiveness of Orthokeratology in Myopia Control". The high prevalence of myopia - especially in Asian countries - is well documented, as are the sight-threatening complications of high or degenerative myopia. Retinal detachment, glaucoma, vitreal degeneration and focal retinal changes may occur secondary to the progressive axial elongation of the e...
What is the current status of trial NCT03465748?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-05-01. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03465748?
The interventions under investigation include: OrthoK (DEVICE).
Who is sponsoring clinical trial NCT03465748?
This trial is sponsored by Illinois College of Optometry, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.